                         SEQUENCE LISTING

<110>  GEORGETOWN UNIVERSITY
       THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE 
       SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
 
<120>  NANOPARTICLE TO TARGET CANCER

<130>  8031-96602-02

<150>  US 62/309,250
<151>  2016-03-16

<160>  4     

<170>  PatentIn version 3.5

<210>  1
<211>  19
<212>  RNA
<213>  Artificial Sequence

<220>
<223>  Synthetic oligonucleotide

<400>  1
gugcugagga ugagaacua                                                    19


<210>  2
<211>  19
<212>  RNA
<213>  Artificial Sequence

<220>
<223>  Synthetic oligonucleotide

<400>  2
gaugcacccu uagguacag                                                    19


<210>  3
<211>  19
<212>  RNA
<213>  Artificial Sequence

<220>
<223>  Synthetic oligonucleotide

<400>  3
agaagaagcc uauggaugg                                                    19


<210>  4
<211>  66
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic polynucleotide

<400>  4
catggtgcag gtgtggctgg gattcatttg ccggtgctgg tgcgtccgcg gccgctaatc       60

ctgttc                                                                  66


